Explore Wegovy costs, including insurance coverage, self-pay prices, savings programs, and financing options to help pay for treatment.
Last updated September 2026
If your doctor has prescribed Wegovy, one of your first questions is probably what it will really cost. Here’s what to know. Wegovy isn’t a one-time expense. You take it week after week, so the number that matters is what you’ll pay each month, after any insurance or savings program.
The price ranges a lot from one person to the next. It depends on your insurance, your dose, and whether you use the manufacturer’s program. Below, we’ll cover what Wegovy costs, why the price varies so much, how insurance and Medicare change what you pay, and where financing does and doesn’t fit.
The right treatment depends on your health history and goals. Talk with your healthcare provider about whether Wegovy is right for you, and make that decision with your prescriber, not for financial reasons alone.
What you pay depends on your insurance, your dose, and whether you use the manufacturer’s program. The same medicine can cost one person $25 a month and another more than $1,000.
Here is what most people can expect to pay. Prices can change, so confirm the current cost with the manufacturer, your pharmacy, or your plan before you budget.
| How You Pay | Typical Monthly Cost | Details |
|---|---|---|
| Commercial insurance + savings card | As little as $25 | Commercial plans only; not Medicare or Medicaid. |
| Self-pay injection, new patient | $199 | First two months, through the manufacturer. |
| Self-pay injection, ongoing | $349 | Standard doses; the 7.2 mg high dose is $399. |
| Self-pay Wegovy pill | $149 to $299 | By dose: $149 at 1.5 mg, up to $299 at 9 mg and 25 mg. |
| Full list price (no help) | About $1,350 | Per 28-day supply; almost no one pays this directly. |
Self-pay and savings-card prices are from NovoCare (Novo Nordisk); list price verified via GoodRx (2026). The $199 intro price runs through December 31, 2026. Prices are set by the manufacturer, your plan, and the pharmacy, and are not a quote.
Wegovy and Ozempic are the same medicine, semaglutide, with different labels. Wegovy is approved for weight loss and Ozempic for type 2 diabetes. That label is what decides whether your insurance pays.
This trips a lot of people up, so it is worth being clear. The active drug is identical, but insurance follows the approved use, not the molecule. Many plans cover semaglutide for diabetes yet exclude it for weight loss, which is why Ozempic is often covered and Wegovy is often not. If you are treating diabetes rather than weight, see our guide to Ozempic costs. For weight loss, Wegovy is the version with the obesity label, so it is the one a weight-loss benefit is written for.
Some commercial plans cover Wegovy for weight loss, and plenty exclude it. Coverage is often stronger when it is prescribed to lower heart risk.
Because Wegovy carries the obesity label, a plan with weight-loss coverage may pay for it. Many employer plans leave that benefit out, though, and some cut it back in 2026. Coverage also tends to be firmer when Wegovy is prescribed to reduce cardiovascular risk in someone with obesity, rather than for weight loss alone. The quickest way to find out is to call the number on your insurance card, or check your plan’s drug list online, and ask two things: is Wegovy covered, and does it need prior authorization? If a plan turns you down, that is not always the end. Ask your prescriber’s office to help you appeal, especially if there is a heart-health reason for the prescription.
Medicare covers Wegovy for obesity only through a temporary Bridge Program at $50 a month, not through standard Part D.
Standard Part D still cannot cover a drug for weight loss on its own, but a temporary GLP-1 Bridge Program that started July 1, 2026 offers Wegovy for obesity at a flat $50 a month if you meet the BMI rules and get prior approval. The program covers both the Wegovy injection and the pill. The $50 does not count toward your Part D deductible or your yearly out-of-pocket limit. Looking ahead, Medicare has also negotiated a semaglutide price of $274 for a 30-day supply that takes effect in 2027 for Part D.
Before you think about borrowing, check the programs that lower the price of the medicine itself. For a monthly cost, a lower price helps you far more than a way to finance a higher one.
Be cautious with heavily discounted “compounded” semaglutide advertised online. After the FDA ended the semaglutide shortage in 2025, routine compounding is no longer permitted, so confirm that any source is legitimate and works with a licensed prescriber before paying.
If, after checking insurance and manufacturer programs, you have a larger one-time cost you want to spread over time, such as several months bought up front, you can check current prequalified offers from lenders in our partner network below. Comparing prequalified offers uses a soft credit check, so it won’t affect your credit score.
For a cost that repeats every month, borrowing is usually not the most sustainable approach. A loan can help with a specific, larger expense, but it is a poor fit for an open-ended monthly refill.
The reason is simple. If you borrow to cover a refill one month, the next month’s refill still arrives, and so does the payment on what you already borrowed. Over time that can leave you paying for past refills and new ones at once, with interest added on top. For an ongoing medication, it usually works better to build the monthly cost into your budget using insurance, manufacturer programs, and a health account where they apply. That said, if paying for a larger chunk at once would help, say several months up front or a stretch while an appeal is pending, spreading that defined amount over a term you choose can be a reasonable way to stay on your treatment. The right choice depends on your budget, so go with what works for you.
In many cases, yes. Wegovy may qualify as an eligible medical expense when it is prescribed to treat obesity as a diagnosed condition, though eligibility depends on IRS rules and your plan.
Because a health savings account or flexible spending account uses pre-tax dollars, it can lower what an eligible prescription really costs you. Whether Wegovy qualifies can depend on medical necessity and your plan’s rules, and some plans ask for a letter of medical necessity, so it is worth confirming with your plan administrator. You can review the general framework in IRS Publication 502. Keep in mind that FSA balances are often use-it-or-lose-it within a plan year.
If you do decide to finance a larger eligible cost, look at the full picture rather than the monthly payment alone. A lower monthly payment stretched over a longer term can mean paying more overall.
When comparing offers, weigh:
Prequalifying through a marketplace lets you place comparable offers side by side so these details are easier to weigh. You can check your rate with our partner SuperMoney in about two minutes, using a soft credit check that does not affect your credit score.
Through the manufacturer, the injection is $199 a month for your first two months, then $349. The Wegovy pill runs about $149 to $299 a month by dose. That is far below the list price of about $1,350 a month, which almost no one pays directly.
Yes. Novo Nordisk, the maker of Wegovy, offers a savings card, which you may also see called a coupon or copay card, available through the manufacturer’s website. It can lower your cost to as little as $25 a month if you have commercial insurance that covers Wegovy, up to $100 off per fill. It does not reduce the cash or self-pay price, and it is not available with Medicare, Medicaid, or other government coverage. Terms can change, so confirm the current offer with the manufacturer.
You would need commercial insurance that covers Wegovy, plus the manufacturer’s savings card. The card does not work with Medicare, Medicaid, or other government coverage.
Not through standard Part D, which cannot cover a drug for weight loss on its own. A temporary GLP-1 Bridge Program covers Wegovy for obesity at $50 a month, starting July 2026, if you meet the BMI rules and get prior approval. It covers both the injection and the pill.
They are the same medicine, semaglutide, with different names. Wegovy is approved for weight loss and Ozempic for type 2 diabetes. That labeling is why insurance often covers one and not the other, even though the drug is identical.
They are close at manufacturer-direct prices. Wegovy is $199 to start, then $349 a month for the injection, while Zepbound’s self-pay vials start at $299. Compare the current price for your specific dose, since the numbers shift by dose and over time.
Often, when it is prescribed to treat obesity as a diagnosed condition, though eligibility depends on IRS rules and your plan. Some plans ask for a letter of medical necessity, so confirm with your plan administrator before relying on it.
Mostly no. After the FDA ended the semaglutide shortage in 2025, routine compounding is no longer permitted, and only narrow, patient-specific cases remain. Treat cheap compounded offers with caution and confirm the source is legitimate.
For a cost that repeats every month, borrowing is usually not the most sustainable approach, since you can end up paying for past refills and new ones at the same time, plus interest. Financing fits a larger one-time cost better. For an ongoing refill, building the monthly cost into your budget with insurance and manufacturer programs tends to work better, though spreading a defined amount can help if money is tight.
Start by finding your real monthly out-of-pocket cost, then plan for it over the length of treatment rather than only the first prescription.
Check your insurance and the savings card first, since those can change what you pay more than the way you cover the balance. Without coverage, the manufacturer’s self-pay price of $199 to start and then $349 is far below the list price, and on Medicare for obesity it is worth checking the Bridge Program. An HSA or FSA can help with an eligible cost. Because Wegovy is usually a recurring expense, borrowing suits a larger one-time cost better than routine monthly refills, and any financing spreads a cost over time rather than lowering it. Whatever you decide, confirm the price with your prescriber or pharmacy, and if you compare financing, weigh the APR, fees, term, monthly payment, and total repayment before choosing.
Are you a weight-loss clinic or medical provider? See how to offer your patients monthly payment options.
Disclosure: FigCare Pay is not a lender, broker, or credit decision-maker. When you select “View My Offers,” you are redirected to an independent third-party loan marketplace where lenders determine all rates, terms, and approvals; FigCare Pay may receive referral compensation. Prequalification uses a soft credit check with no credit impact, though completing an official loan application may require a hard inquiry. All prices shown are examples that can change and are not a quote for your medication. This page is general information only and is not medical, financial, tax, or legal advice.
YOUR ESTIMATE
MONTHLY PAYMENT
FigCare Pay supports healthcare businesses through two powerful financing approaches.
Make the cost of healthcare easier to manage with financing options that let you pay over time instead of covering the full cost upfront.
Receive funding directly while your patients manage their payments over time.
Compare financing and payment options for weight loss treatments, medications, injections, and bariatric surgery.
